Thyroid News

Adults with primary hyperparathyroidism who undergo parathyroidectomy have improved estimated bone strength 2 years after surgery, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Patients with high free thyroxine levels had an increased risk for incident atrial fibrillation, according to a systematic review published in Circulation.

The use of lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer in adults was relatively effective, but adverse events are common and should be monitored, study data show.

Recent findings from a large international genetic database provided new insight on genetic mutations known to cause thyroid cancer, according to a press release from Princeton University.

Results of a retrospective study conducted in South Korea demonstrated that most patients with metastatic differentiated thyroid cancer confined to the lungs had favorable outcomes.

In iodine-deficient pregnant women, supplementation with daily oral iodine did not affect the neurodevelopment of offspring at age 5 to 6 years, according to findings from a randomized controlled trial.

Malignant thyroid nodules are more likely to grow at least 2 mm per year and increase in volume compared with benign thyroid nodules, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Adults with diabetes or prediabetes have a similar rate of thyroid disorders as healthy adults, according to findings from researchers in Iran.

Adults who receive intensive multimodal therapy for treatment of anaplastic thyroid cancer are likely to have longer progression-free survival and overall survival compared with those treated with palliative therapy, study data show.

Patients treated with immune checkpoint inhibitors, including CTLA-4 and PD-1 inhibitors, are at an increased risk for developing endocrine immune-related adverse events, particularly thyroid dysfunction, according to research reported in Clinical Endocrinology.